The Scientist

» autoimmune disease, culture and immunology

Most Recent

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

1 Comment

image: Speaking of Science

Speaking of Science

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: The 2016 Salary Survey Is Here

The 2016 Salary Survey Is Here

By | March 18, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Student Fights Harassment with Wikipedia

Student Fights Harassment with Wikipedia

By | March 10, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

8 Comments

image: More Support for Allergen-Exposure Strategy

More Support for Allergen-Exposure Strategy

By | March 8, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Viral Remnants Help Regulate Human Immunity

Viral Remnants Help Regulate Human Immunity

By | March 3, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

2 Comments

image: Amoebae Have Human-Like Immunity

Amoebae Have Human-Like Immunity

By | March 2, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech